跳至主要内容
临床试验/DRKS00030097
DRKS00030097已完成不适用

Intraoperative perfusion assessment during kidney transplantation

niversitätsklinikum Mannheim0 个研究点目标入组 26 人开始时间: 2022年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
26

研究概览

简要总结

The O2C tissue spectrometry device provides a quantitative method of microperfusion assessment that can be employed during kidney transplantation as an easy-to-use and highly sensitive alternative to ICG fluorescence angiography. Intraoperative microvascular flow and velocity in the allograft cortex after reperfusion predicted DGF with a sensitivity of 100% and a specificity of 82%. Threshold values of 57 A.U. for microvascular flow and 13 A.U. for microvascular velocity were identified by an ROC analysis. This study, therefore, confirmed that impairment of microperfusion of the allograft cortex directly after reperfusion was a key indicator for the occurrence of DGF after kidney transplantation. Our results support the combined use of intraoperative duplex sonography, for macrovascular quality control, and quantitative microperfusion assessment, such as O2C spectrometry, for individual risk stratification to guide subsequent postoperative management.

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 99 Years(—)
性别
All

入选标准

  • All patients scheduled for kidney transplantation in our center.

排除标准

  • allergy to iodine or ICG, severe hepatic dysfunction, pregnancy, hyperthyroidism, pulmonary hypertension and the logistical availability of both technical tools for quantitative perfusion assessment (O2C and SPY Elite)

研究者

发起方
niversitätsklinikum Mannheim

相似试验